Victory Capital Management Inc V Tv Therapeutics Inc. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$1.74 - $3.19 $2,361 - $4,328	-1,357 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$1.63 - $3.75 $37 - $86	-23 Reduced 1.67%	1,357 $3,000
Q4 2019 Feb 04, 2020	SELL	$1.37 - $1.97 $15 - $21	-11 Reduced 0.79%	1,380 $3,000
Q3 2019 Nov 12, 2019	BUY	$1.26 - $1.77 $1,752 - $2,462	1,391 New	1,391 $2,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.25B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.